Flashblood
Flashblood | |
---|---|
Synonyms | N/A |
Pronounce | N/A |
Specialty | N/A |
Symptoms | Euphoria, drowsiness, nausea, vomiting, respiratory depression |
Complications | HIV/AIDS, hepatitis, overdose |
Onset | Immediate |
Duration | Short-term |
Types | N/A |
Causes | Intravenous drug use |
Risks | Bloodborne infections |
Diagnosis | N/A |
Differential diagnosis | N/A |
Prevention | Harm reduction, needle exchange programs |
Treatment | Addiction treatment, antiretroviral therapy |
Medication | N/A |
Prognosis | N/A |
Frequency | N/A |
Deaths | N/A |
Flashblood is a high-risk practice associated with intravenous drug use, particularly among users of heroin and other opioids. It involves the withdrawal of blood from a person who has recently injected drugs and the subsequent injection of that blood into another person. This practice is primarily reported in regions with limited access to drugs and is driven by the desire to experience the euphoria associated with the drug.
Mechanism[edit | edit source]
Flashblood involves the transfer of blood that contains residual amounts of the drug. The recipient injects this blood in an attempt to achieve a similar psychoactive effect. However, the concentration of the drug in the blood is significantly lower than in a direct injection, leading to a reduced effect.
Health Risks[edit | edit source]
The practice of flashblood carries significant health risks, primarily due to the potential transmission of bloodborne infections such as HIV/AIDS and hepatitis. The sharing of needles and blood increases the likelihood of spreading these infections among users. Additionally, there is a risk of overdose if the concentration of the drug in the blood is underestimated.
Prevention and Harm Reduction[edit | edit source]
Efforts to reduce the practice of flashblood focus on harm reduction strategies. These include the implementation of needle exchange programs and education on the risks associated with sharing needles and blood. Providing access to addiction treatment and antiretroviral therapy for those at risk of or living with HIV/AIDS is also crucial.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
- [Harm Reduction Coalition](https://harmreduction.org/)
- [World Health Organization: HIV/AIDS](https://www.who.int/hiv/en/)
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD